Fermented Camellia sinensis, Fu Zhuan Tea, regulates hyperlipidemia and transcription factors involved in lipid catabolism

Food Research International

Volumn 44, Issue 9, 2011, Pages 2999-3005

  Fu, Donghe ^a   Ryan, Elizabeth P ^b   Huang, Jianan ^a   Liu, Zhonghua ^a   Weir, Tiffany L ^b   Snook, Randall L ^c   Ryan, Timothy P ^d  

^a HUNAN AGRICULTURAL UNIVERSITY   (China)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c Advanced Integrative Medicine   (United States)

^d Occupational Health Epidemiology   (United States)

Author keywords

Blood lipids; Post fermentation tea; Transcriptional regulation

Indexed keywords

BIOACTIVE FRACTIONS; CAMELLIA SINENSIS; CARDIO-VASCULAR DISEASE; CHEMICAL CHARACTERIZATION; CHINESE BRICKS; DOSE-DEPENDENT; FACTOR ACTIVATION; FARNESOID X RECEPTORS; HYPERLIPIDEMIA; ISOFORMS; LABORATORY MODELS; LDL CHOLESTEROL; LIPID LEVELS; LIPID LOWERING; LIPID METABOLISMS; LIVER CELLS; METHOD OF PROCESSING; MOLECULAR TARGETS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR; PILOT STUDIES; POST FERMENTATION TEA; REGULATION OF TRANSCRIPTION; REPORTER GENE ASSAYS; THERAPEUTIC EFFICACY; TRANSCRIPTIONAL REGULATION; TYPE-2 DIABETES;

BLOOD; CYTOLOGY; GENES; LIPIDS; METABOLISM; TRANSCRIPTION FACTORS;

TRANSCRIPTION;

CAMELLIA SINENSIS; FUNGI;

EID: 80054722103     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2011.07.008     Document Type: Article

References (39)

1. Allen, J. K., Himmelfarb, C. R., Szanton, S. L., Bone, L., Hill, M. N., & Levine, D. M. (2011). COACH trial: A randomized controlled trial of nurse practitioner/community health worker cardiovascular disease risk reduction in urban community health centers: Rationale and design. Contemporary Clinical Trials.
2. Bursill C.A., Roach P.D. Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells. Journal of Agricultural and Food Chemistry 2006, 54:1621-1626.
3. Cao A., Li H., Zhou Y., Wu M., Liu J. Long chain acyl-CoA synthetase-3 is amolecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells. The Journal of Biological Chemistry 2010, 285:16664-16674.
4. Cariou B., van Harmelen K., Duran-Sandoval D., van Dijk T.H., Grefhorst A., Abdelkarim M., Caron S., Torpier G., Fruchart J.C., Gonzalez F.J., Kuipers F., Staels B. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. The Journal of Biological Chemistry 2006, 281:11039-11049.
5. Chao P.C., Huang C.N., Hsu C.C., Yin M.C., Guo Y.R. Association of dietary AGEs with circulating AGEs, glycated LDL, IL-1alpha and MCP-1 levels in type 2 diabetic patients. European Journal of Nutrition 2010, 49:429-434.
6. Chen W.D., Wang Y.D., Meng Z., Zhang L., Huang W. Nuclear bile acid receptor FXR in the hepatic regeneration. Biochimica et Biophysica Acta. Molecular Basis of Disease 2011, 1812(8):888.
7. Crespy V., Williamson G. A review of the health effects of green tea catechins in in vivo animal models. The Journal of Nutrition 2004, 134:3431S-3440S.
8. Fonseca, V., Desouza, C., & Khan, A. N. (2010). Adding subcutaneous liraglutide to metformin reduces HbA1c more than adding oral sitagliptin in patients whose type 2 diabetes is poorly controlled with metformin alone. Evidence-Based Medicine, 15, 115-116.
9. Frank J., George T.W., Lodge J.K., Rodriguez-Mateos A.M., Spencer J.P., Minihane A.M., Rimbach G. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. The Journal of Nutrition 2009, 139:58-62.
10. Furuyashiki T., Nagayasu H., Aoki Y., Bessho H., Hashimoto T., Kanazawa K., Ashida H. Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPAR & gamma; 2 and C/EBP & alpha; in 3 T3-L1 cells. Bioscience, Biotechnology, and Biochemistry 2004, 68:2353-2359.
11. Hodgson J.M., Puddey I.B., Croft K.D., Burke V., Mori T.A., Caccetta R.A.-A., Beilin L.J. Acute effects of ingestion of black and green tea on lipoprotein oxidation. The American Journal of Clinical Nutrition 2000, 71:1103-1107.
12. Huang Q. Study on changes of active components in Dark tea (Fu Zhuan Tea) during liquid fermentation by Eurotium cristatum. Journal of Tea Science 2007, 28(12):231-234.
13. Intra J., Kuo S.M. Physiological levels of tea catechins increase cellular lipid antioxidant activity of vitamin C and vitamin E in human intestinal caco-2 cells. Chemico-Biological Interactions 2007, 169:91-99.
14. Jeng K.C., Chen C.S., Fang Y.P., Hou R.C., Chen Y.S. Effect of microbial fermentation on content of statin, GABA, and polyphenols in Pu-Erh tea. Journal of Agricultural and Food Chemistry 2007, 55:8787-8792.
15. Khan N., Mukhtar H. Tea polyphenols for health promotion. Life Sciences 2007, 81:519-533.
16. Kim, H., Hiraishi, A., Tsuchiya, K., & Sakamoto, K. (2010). (-) Epigallocatechin gallate suppresses the differentiation of 3T3-L1 preadipocytes through transcription factors FoxO1 and SREBP1c. Cytotechnology, 62, 245-255.
17. KunBo S.L.H.J.L.Z.H.H.W. Study on the activity of Dark tea extracts to FXR adn LXR model. Journal of Tea Science 2009, 29:131-135.
18. Ling, T. J., Wan, X. C., Ling, W. W., Zhang, Z. Z., Xia, T., Li, D. X., & Hou, R. Y. (2010). New triterpenoids and other constituents from a special microbial-fermented tea-Fu Zhuan brick tea. Journal of Agricultural and Food Chemistry, 58, 4945-4950.
19. Maatta-Riihinen K.R., Kahkonen M.P., Torronen A.R., Heinonen I.M. Catechins and procyanidins in berries of vaccinium species and their antioxidant activity. Journal of Agricultural and Food Chemistry 2005, 53:8485-8491.
20. Michael L.F., Schkeryantz Jeffrey M., Burris Thomas P. The pharmacology of LXR. Mini Reviews in Medicinal Chemistry 2005, 5:729-740.
21. Murase T., Nagasawa A., Suzuki J., Hase T., Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. International Journal of Obesity Related Metabolic Disorders 2002, 26(11):1459-1464.
22. Na H.-J., Lee G., Oh H.-Y., Jeon K.-S., Kwon H.-J., Ha K.-S., Lee H., Kwon Y.-G., Kim Y.-M. 4-O-Methylgallic acid suppresses inflammation-associated gene expression by inhibition of redox-based NF-[kappa]B activation. International Immunopharmacology 2006, 6:1597-1608.
23. Salam N.K., Huang T.H., Kota B.P., Kim M.S., Li Y., Hibbs D.E. Novel PPAR-gamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study. Chemical Biology & Drug Design 2008, 71(1):57-70.
24. Saito S.T., Gosmann G., Pungartnik C., Brendel M. Green tea extract-patents and diversity of uses. Recent Patents on Food, Nutrition & Agriculture 2009, 1:203-215.
25. Sharma V., Rao L.J. A thought on the biological activities of black tea. Critical Reviews in Food Science and Nutrition 2009, 49:379-404.
26. Steptoe A., Gibson E.L., Vuononvirta R., Hamer M., Wardle J., Rycroft J.A., Martin J.F., Erusalimsky J.D. The effects of chronic tea intake on platelet activation and inflammation: A double-blind placebo controlled trial. Atherosclerosis 2007, 193:277-282.
27. Stote K.S., Baer D.J. Tea consumption may improve biomarkers of insulin sensitivity and risk factors for diabetes. The Journal of Nutrition 2008, 138:1584S-1588S.
28. Torres J.L., Lozano C., Maher P. Conjugation of catechins with cysteine generates antioxidant compounds with enhanced neuroprotective activity. Phytochemistry 2005, 66:2032-2037.
29. Trauner M., Claudel T., Fickert P., Moustafa T., Wagner M. Bile acids as regulators of hepatic lipid and glucose metabolism. Digestive Diseases 2010, 28:220-224.
30. Wang Y., Ho C.T. Polyphenolic chemistry of tea and coffee: A century of progress. Journal of Agricultural and Food Chemistry 2009, 57:8109-8114.
31. Wu Y.Y., Ding L., Xia H.L., Tu Y.Y. Analysis of the major chemical compositions in Fuzhuan brick-tea and its effect on activities of pancreatic enzymes in vitro. African Journal of Biotechnology 2010, 9:6748-6754.
32. Xiao W.-j. Study on the regulation of blood lipid by Fu Zhuan Tea. Journal of Tea Science 2007, 27(3):211-214.
33. Xiao W.-J. Study on the toxicity experiments of Fu Zhuan Tea. Journal of Tea Science 2007, 27(4):307-310.
34. Xie G., Ye M., Wang Y., Ni Y., Su M., Huang H., Qiu M., Zhao A., Zheng X., Chen T., Jia W. Characterization of pu-erh tea using chemical and metabolic profiling approaches. Journal of Agricultural and Food Chemistry 2009, 57:3046-3054.
35. Yang M.-H., Wang C.-H., Chen H.-L. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. The Journal of Nutritional Biochemistry 2001, 12:14-20.
36. Ye J.M., Tid-Ang J., Turner N., Zeng X.Y., Li H.Y., Cooney G.J., Wulff E.M., Sauerberg P., Kraegen E.W. Peroxisome proliferator-activated receptor-delta agonists have opposing effects on insulin resistance in high fat fed rats and mice due to different metabolic responses in muscle. British Journal of Pharmacology 2011, 163(3):556-566.
37. Yu Y.H., Wang P.H., Cheng W.T., Mersmann H.J., Wu S.C., Ding S.T. Porcine peroxisome proliferator-activated receptor delta mediates the lipolytic effects of dietary fish oil to reduce body fat deposition. Journal of Animal Science 2010, 88:2009-2018.
38. Zaveri N.T. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sciences 2006, 78:2073-2080.
39. Zhu, Q. (2006). Comparative Study on the Components of Pu'er Tea and Fu-Brick Tea with Black Tea by LC-MS. Journal of Tea Science, 26(3).